+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer

Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer

Mutation Research 769: 108-112

The PI3K/AKT signal transduction pathway has distinct functional roles in tumor progression. PIK3CA was reported to harbor the hot-spot in many types of tumor. Akt, the downstream of PI3K, its family members especially AKT2 activation in human cancer has been extensively studied, but its activation by mutation was less reported. The occurrence of PIK3CA and AKT2 mutations in a variety of cancers indicates their important involvement in carcinogenesis. Therefore, we investigated their mutation frequencies in gastric cancer (GC) in China. In our study, we selected hot-spot related exons 9, 18 and 20 of PIK3CA and kinase domain exons 6-14 of AKT2 genes were screened in 10 GC cell lines, 100 advanced primary GC and matched normal tissues. Denaturing high performance liquid chromatography (DHPLC) and DNA sequencing were used to analyze the mutations in the two genes. Two point mutations in the PIK3CA gene were identified in 4 of 10 GC cell lines and in 4 of 100 GC primary tumors. Two polymorphisms in AKT2 were detected in 19 of 100 GC primary tumors. One point mutation in AKT2 was detected in 1 of 10 GC cell lines and 3 of 100 GC primary tumors but no hot spot variation was detected. Our results indicate that PIK3CA and AKT2 mutations occurred at low frequency in GC, and suggest that the PIK3CA/AKT2 pathway might engage other events during gastric carcinogenesis.

(PDF emailed within 0-6 h: $19.90)

Accession: 058448860

Download citation: RISBibTeXText

PMID: 25771729

DOI: 10.1016/j.mrfmmm.2014.07.007

Related references

PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene. Advances in Clinical and Experimental Medicine 27(7): 963-969, 2018

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms. Cancer Biology and Therapy 5(7): 779-785, 2006

The prevalence of PIK3CA mutations in gastric and colon cancer. European Journal of Cancer 41(11): 1649-1654, 2005

The High Frequency of PIK3CA Mutations in Iranian Breast Cancer Patients. Cancer Investigation 35(1): 36-42, 2016

Associations of PIK3CA mutations with clinical features and prognosis in gastric cancer. Future Oncology 2019, 2019

Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer. Molecular Medicine Reports 12(1): 1219-1224, 2016

PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer. Oncotarget 8(53): 90948-90958, 2017

Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer. Journal of Surgical Research 212: 195-204, 2017

High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer. JAMA Otolaryngology-- Head and Neck Surgery 139(6): 617-622, 2013

Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer. International Journal of Cancer 122(5): 1189-1194, 2007

Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations. Annals of Oncology 28(5): 1005-1014, 2018

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases. Springerplus 2: 464, 2013

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer. Bmc Research Notes 7: 271, 2015

The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type. Journal of Experimental and Clinical Cancer Research 29: 32, 2010

Chitosan/PIK3CA siRNA nanoparticle-mediated PIK3CA gene interference decreases the invasive capacity of gastric cancer cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 34(10): 1503-1506, 2015